NCT04009434

Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.

Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,162 (estimated)
• Sponsor: Technische Universität Dresden · Academic / Other
• Sex: All
• Age: 18 Years – 89 Years
• Healthy volunteers: Not accepted

Summary

To evaluate whether patients after successful transfemoral transcatheter aortic valve implantation (TAVI), who have concomitant, moderate to severe mitral regurgitation (MR) benefit from an additional treatment of this valve disease as well.

Conditions

• Aortic Stenosis
• Mitral Regurgitation

Interventions

Type	Name	Description
DEVICE	Mitral Valve Clipping	Patients receive treatment for mitral regurgitation with mitral valve clipping including standard drug therapy.
DEVICE	TAVI	Transfemoral transcatheter aortic valve implantation plus optimal standard of care therapy.

Timeline

• Start date: 2019-12-01
• Primary completion: 2023-08-01
• Completion: 2023-08-01
• First posted: 2019-07-05
• Last updated: 2020-02-05

Locations

1 site across 1 country: Germany